ArticleFrontiers in immunology2025
The salvage therapy utilizing human umbilical cord-derived mesenchymal stem cells for the treatment of critically ill patients with COVID-19.
Weiqi Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.